logo image
search icon
Bird Flu Market

Bird Flu Market Size, Share & Trends Analysis Report By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, Others), By Treatment Type, By Animal Type, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2347 | Published : 2024-03-07 | Pages: 180 | Format: PDF/EXCEL

Bird Flu Market Size is valued at USD 1.41 Bn in 2023 and is predicted to reach USD 2.17 Bn by the year 2031 at a 5.82% CAGR during the forecast period for 2024-2031.

Bird Flu Market

Bird flu is an infectious type virus that primarily affects birds which can cause severe disease in birds, leading to high mortality rates as well these viruses typically cause milder symptoms and may go unnoticed. The market related to bird flu infection spans pharmaceuticals, vaccines, diagnostics, and poultry industry management, driven by the need to prevent, diagnose, and treat avian influenza outbreaks. Demand for antiviral drugs, human vaccines against potential pandemic strains, and rapid early detection diagnostic tools are key components. The poultry industry, significantly affected by avian influenza, invests in biosecurity measures, surveillance, and vaccination to mitigate economic losses and trade restrictions. Public health preparedness, including government and international organization efforts in surveillance and emergency response, plays a crucial role. 

Furthermore, because labour costs are low and raw materials are easily accessible in emerging nations, large firms are concentrating on moving their production facilities there. The market for bird flu treatments is anticipated to develop due to these causes. Additionally, it is anticipated that underdeveloped infrastructure in developing nations would restrict research and development capacities, hence impeding the expansion of the bird flu market. But rising government expenditure on infrastructure development and rising investment by big companies in product development are two things that should open up new doors for businesses in the target market.

Competitive Landscape

Some Major Key Players In The Bird Flu Market:

  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Zoetis
  • Merck & Co.
  • Ringpu Biology
  • Yebio Bioengineering
  • FATRO
  • CAVAC
  • ChengDu Tecbond
  • QYH Biotech
  • Elanco
  • Phibro Animal Health
  • Vetoquinol
  • Hipra
  • Venkys
  • Anicon Labor GmbH
  • Bioveta
  • Lohmann Animal Health
  • Biogenesis Bago
  • Sanofi
  • Hoffmann-La Roche Ltd.
  • Mallinckrodt
  • GlaxoSmithKline plc
  • Novartis AG
  • Bayer AG
  • Eli Lilly and Company
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Bimeda, Inc.
  • Phibro Animal Health Corporation
  • Medion
  • Other Prominent Players

Market Segmentation:

The bird flu market can be segmented based on Virus Type, Test Type, Treatment Type, and Animal Type. By Virus Type, the market is segmented into H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, and Others. By Test Type, the market is segmented into PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, and Others. By Treatment Type, the market is segmented into Vaccines, Antiviral Medication, Immunomodulators, and Others; by Animal Type, the market is segmented into Chickens, Ducks, Geese & Swans, Pigeons, Guinea Fowls, Turkeys, and Others.

Most Widespread Virus Type Segment Is H5N1.

The pathogenic influenza A virus subtype H5N1 is an emerging bird flu (Avian influenza) virus causing global concern as a potential pandemic threat. H5N1 is a large threat virus in Asia because of infected poultry due to low hygiene conditions and close quarters. It is easy for humans to be safe from bird infection, but human-to-human transmission is more difficult without prolonged contact. Public health officials believe avian flu strains may mutate to become easily transmissible between humans.

Most human cases of bird flu result from either handling dead infected birds or contact with infected fluids, which refers to being spread through contaminated surfaces and droppings. Most seasonal wild birds have only a mild form of the H5N1 strain; some domesticated birds, such as chickens or turkeys, are known to be infected. H5N1 can become much more deadly because the birds are often in close contact.

Segments PAPR Is The Most Widespread Prevention Method.

Along with proper infection control and personal protective equipment (PPE), the chance of infection by bird flu is low. Protecting the eyes, nose, mouth, and hands is crucial for prevention in poultry farms. Felicitous personal protective equipment includes aprons or coveralls, gloves, boots covers, and a head cover. Disposable PPE is recommended. An N-95 respirator with safety goggles is also part of the appropriate PPE. A fueled air purifying respirator (PAPR) with a helmet and face shield is also an option.

North America Has A Significant Revenue Share In The Global Bird Flu Market Region.

North America has taken the lead as the region of choice. Numerous companies producing avian influenza vaccines and diagnostics are in the United States. North America has taken the lead in epidemic planning and prevention strategies thanks to the large chicken markets in the United States and Canada. Tight food safety laws necessitate that commercial poultry farms implement biosecurity measures on a large scale. Major R&D expenditures have been made by top American pharmaceutical corporations to create avian flu vaccinations that are universally effective. This enables North America to combat new strains of avian influenza more effectively before they become widespread worldwide.

Recent Developments:

  • In July 2023, The vaccination campaign scheduled to commence in October 2023 in France have chosen Boehringer Ingelheim, a German company, to supply the required quantity of 80 million doses of avian influenza vaccines. By commencing this campaign, France achieved the distinction of being the inaugural member state of the European Union to immunize poultry against avian influenza. Positive test results for vaccines manufactured in France by Ceva Animal Health and Boehringer Ingelheim were reported by officials of the Ministry of Agriculture last month. 

Bird Flu Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 1.41 Bn

Revenue Forecast In 2031

USD 2.17 Bn

Growth Rate CAGR

CAGR of 5.82 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Virus Type, Test Type, Treatment Type, and Animal Type.

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea

Competitive Landscape

Boehringer Ingelheim, Ceva Santé Animale, Zoetis, Merck & Co., Ringpu Biology, Yebio Bioengineering, FATRO, CAVAC, ChengDu Tecbond, QYH Biotech, Elanco, Phibro Animal Health, Vetoquinol, Hipra, Venkys, Anicon Labor GmbH, Medion Farma Jaya, Bioveta, Lohmann Animal Health and Biogenesis Bago, Sanofi, F. Hoffmann-La Roche Ltd., Mallinckrodt, Elanco, GlaxoSmithKline plc, Novartis AG, Bayer AG, Eli Lilly and Company, AstraZeneca, Johnson & Johnson Private Limited, Bimeda, Inc., Phibro Animal Health Corporation, HIPRA, Medion

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Bird Flu Market Snapshot

Chapter 4. Global Bird Flu Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Virus Type Estimates & Trend Analysis

5.1. by Virus Type & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Virus Type:

5.2.1. H5N1

5.2.2.  H7N9

5.2.3.  H5N6

5.2.4.  H5N8

5.2.5.  H10N8

5.2.6.  H9N2

5.2.7.  Others

Chapter 6. Market Segmentation 2: by Test Type Estimates & Trend Analysis

6.1. by Test Type & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Test Type:

6.2.1. PCR Tests

6.2.2.  ELISA Tests

6.2.3.  Hemagglutination Assays

6.2.4.  Virus Isolation Tests

6.2.5.  Next Generation Sequencing

6.2.6.  Others

Chapter 7. Market Segmentation 3: by Treatment Type Estimates & Trend Analysis

7.1. by Treatment Type & Market Share, 2019 & 2031

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Treatment Type:

7.2.1. Vaccines

7.2.2.  Antiviral Medication

7.2.3.  Immunomodulators

7.2.4.  Others

Chapter 8. Market Segmentation 4: by Animal Type Estimates & Trend Analysis

8.1. by Animal Type & Market Share, 2019 & 2031

8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Animal Type;

8.2.1. Chickens

8.2.2.  Ducks

8.2.3.  Geese & Swans

8.2.4.  Pigeons

8.2.5.  Guinea Fowls

8.2.6. Turkeys

8.2.7.  Others

Chapter 9. Bird Flu Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Virus Type, 2019-2031

9.1.2. North America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031

9.1.3. North America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031

9.1.4. North America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2019-2031

9.1.5. North America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

9.2. Europe

9.2.1. Europe Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Virus Type,2019-2031

9.2.2. Europe Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031

9.2.3. Europe Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031

9.2.4. Europe Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2019-2031

9.2.5. Europe Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

9.3. Asia Pacific

9.3.1. Asia Pacific Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Virus Type, 2019-2031

9.3.2. Asia Pacific Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031

9.3.3. Asia-Pacific Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031

9.3.4. Asia Pacific Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Animal Type ,2019-2031

9.3.5. Asia Pacific Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

9.4. Latin America

9.4.1. Latin America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Virus Type, 2019-2031

9.4.2. Latin America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031

9.4.3. Latin America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031

9.4.4. Latin America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2019-2031

9.4.5. Latin America Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

9.5. Middle East & Africa

9.5.1. Middle East & Africa Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Virus Type, 2019-2031

9.5.2. Middle East & Africa Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2019-2031

9.5.3. Middle East & Africa Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031

9.5.4. Middle East & Africa Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2019-2031

9.5.5. Middle East & Africa Bird Flu Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Boehringer Ingelheim

10.2.2. Ceva Santé Animale

10.2.3. Zoetis

10.2.4. Merck & Co.

10.2.5. Ringpu Biology

10.2.6. Yebio Bioengineering

10.2.7. FATRO

10.2.8. CAVAC

10.2.9. ChengDu Tecbond

10.2.10. QYH Biotech

10.2.11. Elanco

10.2.12. Phibro Animal Health

10.2.13. Vetoquinol

10.2.14. Hipra

10.2.15. Venkys

10.2.16. Anicon Labor GmbH

10.2.17. Medion Farma Jaya

10.2.18. Bioveta

10.2.19. Lohmann Animal Health

10.2.20. Biogenesis Bago

Segmentation of The Bird Flu Market

The Bird Flu Market By Virus Type:

  • H5N1
  • H7N9
  • H5N6
  • H5N8
  • H10N8
  • H9N2
  • Others

Bird Flu Market seg

The Bird Flu Market By Test Type:

  • PCR Tests
  • ELISA Tests
  • Hemagglutination Assays
  • Virus Isolation Tests
  • Next Generation Sequencing
  • Others

The Bird Flu Market By Treatment and Prevention Type:

  • Vaccines
  • Antiviral Medication
  • Immunomodulators
  • POPE
  • PAPER

The Bird Flu Market By Animal Type:

  • Chickens
  • Ducks
  • Geese & Swans
  • Pigeons
  • Guinea Fowls
  • Turkeys
  • Others

The Bird Flu Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Bird Flu Market Size?

Bird Flu Market is expected to grow at a 5.82% CAGR during the forecast period for 2024-2031.

Elanco, GlaxoSmithKline plc, Novartis AG, Bayer AG, Eli Lilly and Company, AstraZeneca, Johnson & Johnson Private Limited, Bimeda, Inc., Phibro Animal

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Veterinary

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach